Quarterly Result15 May 2025, 08:41 pm
Alivus Life Sciences Reports Profit of INR 4,708.88 Million for FY 2024-25
AI Summary
Alivus Life Sciences Ltd. has reported its audited financial results for the quarter and year ended March 31, 2025. The company's revenue from operations stands at INR 23,868.84 Million, with a profit for the period of INR 4,708.88 Million. The total comprehensive income for the year is INR 4,843.79 Million. The company's earnings per equity share (Face Value of = 2/- each) are (a) Basic (INR 38.43) and (b) Diluted (INR 38.38). The company's total assets are INR 34,114.53 Million, with total equity and liabilities at INR 28,504.12 Million.
Key Highlights
- Revenue from operations stands at INR 23,868.84 Million
- Profit for the period is INR 4,708.88 Million
- Total comprehensive income for the year is INR 4,843.79 Million
- Earnings per equity share (Face Value of = 2/- each) are (a) Basic (INR 38.43) and (b) Diluted (INR 38.38)
- Total assets are INR 34,114.53 Million, with total equity and liabilities at INR 28,504.12 Million